Announcements
27 April 2025
Clinical and Translational Neuroscience Accepted for Coverage in Scopus

You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We are pleased to announce that Clinical and Translational Neuroscience (CTN, ISSN: 2514-183X) was selected for coverage in the Scopus indexing database in April 2025. We would like to extend our sincere gratitude to all of the authors, reviewers, and editors who have contributed to this journal and helped us accomplish this achievement.
Clinical and Translational Neuroscience (CTN) is an international, peer-reviewed, open access journal. The journal focuses on translating and developing basic neuroscience research into novel clinical neuroscience applications and therapies. We encourage scientists in the fields of basic and clinical research to publish their results in as much detail as possible so that they can readily be reproduced. There is no restriction on the maximum length of the papers submitted to and published in Clinical and Translational Neuroscience. The journal is owned by the Swiss Federation of Clinical Neuro-Societies and is published quarterly online by MDPI (from Volume 5 Issue 2-2021).
To make the most of the opportunity afforded by this coverage, we would like to invite you to submit your research to CTN. If you are currently working on/have written a paper concerning any topic within the journal’s scope, please submit it via the journal’s website: https://www.mdpi.com/journal/ctn.
CTN Editorial Office